Literature DB >> 2068840

Evaluating the cost impact of intravenous antibiotic dosing frequencies.

R M Foran1, J L Brett, P H Wulf.   

Abstract

Cost differences between antibiotic dosing frequencies were studied at Robert Wood Johnson University Hospital. Developing a complete cost profile between antibiotic alternatives is difficult because of role separation within the hospital. To present a more complete profile, the study analyzed the incremental costs associated with the hospital pharmacy and nursing staffs regarding various dosing frequencies, including different iv admixture and administration methods. Results showed that administration of an antibiotic dose costs approximately $3.35 based on labor and material costs associated with admixture and administration. An average of 4.6 minutes/dose saves nurses up to 23 minutes for each patient who receives an antibiotic dosed once rather than six times daily over a 24-hour period. Costs of administration and admixture should be considered in comparisons of combination therapy with monotherapy when deciding between two therapeutically equivalent alternatives.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068840     DOI: 10.1177/106002809102500516

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  11 in total

1.  Spreadsheet software program to analyse costs beyond drug acquisition price.

Authors:  J A Paladino
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

Review 2.  Nursing home-acquired pneumonia. Treatment options.

Authors:  T J Marrie; K L Slayter
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

3.  Cost-effectiveness comparison of cefepime and ceftazidime using decision analysis.

Authors:  J A Paladino
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

4.  Cost-effectiveness of abbreviating the duration of intravenous antibacterial therapy with oral fluoroquinolones.

Authors:  K M Jensen; J A Paladino
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

5.  Prescribing practice and cost of antibacterial prophylaxis for surgery at a US Veteran Affairs hospital.

Authors:  R A Ryono; K S Jones; R W Coleman; M Holodniy
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

6.  Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections.

Authors:  R Davis; H M Bryson
Journal:  Pharmacoeconomics       Date:  1994-09       Impact factor: 4.981

Review 7.  Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.

Authors:  C M Spencer; H M Bryson
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

8.  Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.

Authors:  D J Walters; J S Solomkin; J A Paladino
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

9.  Cost effectiveness of cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy. For the treatment of febrile episodes in neutropenic patients.

Authors:  J A Paladino; L D Fong; A Forrest; R Ramphal
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981

10.  Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US.

Authors:  Joseph A Paladino; Martin H Adelman; Jerome J Schentag; Paul B Iannini
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.